CTIC logo

CTI BioPharma (CTIC) Total Debt

Annual Total Debt

$49.96 M
-$598.00 K-1.18%

December 31, 2022

Summary

Performance

1-Year Change

-1.18%

3-Year Change

+307.49%

5-Year Change

+256.36%

15-Year Change

+256.36%

CTIC Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$233.65 M
CTIC annual total debt is currently -78.62% below its historical high of $233.65 million

3-Year Low

$49.96 M
CTIC annual total debt is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CTIC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CTIC next annual earnings announcement has not yet been scheduled

OtherCTICbalance sheetmetrics:

Annual Total Debt

$49.96 M
CTIC annual total debt is $49.96 million

Annual Total Liabilities

$143.50 M
CTIC annual total liabilities is $143.50 million

Annual Total Assets

$125.92 M
CTIC annual total assets is $125.92 million

Annual Current Assets

$99.40 M
CTIC annual total current assets is $99.40 million

Quarterly Total Debt

$48.90 M
-$1.06 M-2.13%

March 31, 2023

Summary

Performance

3-Month Change

-2.13%

1-Year Change

+1.14%

3-Year Change

+363.72%

5-Year Change

+245.84%

CTIC Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$233.65 M
CTIC quarterly total debt is currently -79.07% below its historical high of $233.65 million

3-Year Low

$48.34 M
CTIC quarterly total debt is currently +1.14% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
CTIC previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
CTIC next earnings announcement has not yet been scheduled

OtherCTICbalance sheetmetrics:

Quarterly Total Liabilities

$137.62 M
CTIC quarterly total liabilities is $137.62 million

Quarterly Total Assets

$112.27 M
CTIC quarterly total assets is $112.27 million

Quarterly Current Assets

$86.45 M
CTIC quarterly total current assets is $86.45 million

Quarterly Current Liabilities

$68.23 M
CTIC quarterly total current liabilities is $68.23 million

Total Debt Formula

Total Debt = Short Term Debt + Long Term Debt

Annual Total Debt

$49.96 M
CTIC annual total debt is $49.96 million

Annual Long Term Debt

$1.23 M
CTIC annual long term debt is $1.23 million

Annual Short Term Debt

$48.72 M
CTIC annual short term debt is $48.72 million

CTIC Total Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-1.2%+1.1%
3 y3 years+307.5%+363.7%
5 y5 years+256.4%+245.8%

CTIC Total Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-1.2%at low-3.3%-1.1%
5 y5-year-1.2%-86.7%-3.3%-91.8%
alltimeall time-78.6%-100.0%-79.1%-100.0%

CTI BioPharma Total Debt History

DateAnnualQuarterly
Mar 2023
-
$48.90 M(-2.1%)
Dec 2022
$49.96 M(-1.2%)
$49.96 M(+1.5%)
Sep 2022
-
$49.24 M(-0.1%)
Jun 2022
-
$49.30 M(+2.0%)
Mar 2022
-
$48.34 M(-4.4%)
Dec 2021
$50.56 M(+660.4%)
$50.56 M(+4.0%)
Sep 2021
-
$48.62 M(+1118.5%)
Jun 2021
-
$3.99 M(-27.8%)
Mar 2021
-
$5.53 M(-16.8%)
Dec 2020
$6.65 M(-45.8%)
$6.65 M(-5.5%)
Sep 2020
-
$7.04 M(-20.1%)
Jun 2020
-
$8.80 M(-16.5%)
Mar 2020
-
$10.54 M(-14.0%)
Dec 2019
$12.26 M(-12.9%)
$12.26 M(-12.2%)
Sep 2019
-
$13.97 M(-10.9%)
Jun 2019
-
$15.68 M(-9.7%)
Mar 2019
-
$17.36 M(+23.3%)
Dec 2018
$14.08 M(+0.4%)
$14.08 M(-2.2%)
Sep 2018
-
$14.39 M(+0.9%)
Jun 2018
-
$14.26 M(+0.9%)
Mar 2018
-
$14.14 M(+0.8%)
Dec 2017
$14.02 M(-27.2%)
$14.02 M(-5.2%)
Sep 2017
-
$14.79 M(-4.1%)
Jun 2017
-
$15.43 M(-11.2%)
Mar 2017
-
$17.36 M(-9.8%)
Dec 2016
$19.26 M(-65.9%)
$19.26 M(-8.7%)
Sep 2016
-
$21.09 M(-7.8%)
Jun 2016
-
$22.87 M(-7.0%)
Mar 2016
-
$24.60 M(-56.5%)
Dec 2015
$56.49 M(+225.1%)
$56.49 M(+9.4%)
Sep 2015
-
$51.65 M(+0.1%)
Jun 2015
-
$51.62 M(+238.8%)
Mar 2015
-
$15.24 M(-12.3%)
Dec 2014
$17.38 M(+30.6%)
$17.38 M(+26.7%)
Sep 2014
-
$13.71 M(+1.2%)
Jun 2014
-
$13.55 M(+1.2%)
Mar 2014
-
$13.39 M(+0.6%)
Dec 2013
$13.31 M(>+9900.0%)
$13.31 M(+59.5%)
Sep 2013
-
$8.34 M(+1.7%)
Jun 2013
-
$8.20 M(+1.7%)
Mar 2013
-
$8.07 M(>+9900.0%)
Dec 2012
$0.00(0.0%)
$0.00(0.0%)
Sep 2012
-
$0.00(0.0%)
Jun 2012
-
$0.00(0.0%)
Mar 2012
-
$0.00(0.0%)
Dec 2011
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2011
-
$12.43 M(+0.9%)
Jun 2011
-
$12.31 M(-45.1%)
Mar 2011
-
$22.45 M(+0.6%)
Dec 2010
$22.31 M(-65.8%)
$22.31 M(-7.0%)
Sep 2010
-
$23.99 M(-61.6%)
Jun 2010
-
$62.52 M(-4.0%)
Mar 2010
-
$65.12 M(-0.3%)
DateAnnualQuarterly
Dec 2009
$65.31 M(-55.3%)
$65.31 M(+159.4%)
Sep 2009
-
$25.18 M(-64.1%)
Jun 2009
-
$70.13 M(-42.7%)
Mar 2009
-
$122.44 M(-16.2%)
Dec 2008
$146.04 M(-1.5%)
$146.04 M(-18.6%)
Sep 2008
-
$179.40 M(+4.7%)
Jun 2008
-
$171.29 M(+9.8%)
Mar 2008
-
$156.05 M(+5.2%)
Dec 2007
$148.29 M(-11.1%)
$148.29 M(-2.3%)
Sep 2007
-
$151.83 M(-2.8%)
Jun 2007
-
$156.15 M(-4.6%)
Mar 2007
-
$163.76 M(-1.8%)
Dec 2006
$166.72 M(-28.6%)
$166.72 M(-2.6%)
Sep 2006
-
$171.11 M(-4.3%)
Jun 2006
-
$178.79 M(+2.9%)
Mar 2006
-
$173.71 M(-25.7%)
Dec 2005
$233.65 M(+7.9%)
$233.65 M(+20.9%)
Sep 2005
-
$193.23 M(+1.1%)
Jun 2005
-
$191.12 M(-12.2%)
Mar 2005
-
$217.66 M(+0.5%)
Dec 2004
$216.60 M(+12.9%)
$216.60 M(+13.1%)
Sep 2004
-
$191.59 M(-0.1%)
Jun 2004
-
$191.76 M(-0.1%)
Mar 2004
-
$191.90 M(+0.0%)
Dec 2003
$191.87 M(+63.5%)
$191.87 M(-1.6%)
Sep 2003
-
$195.03 M(+1.4%)
Jun 2003
-
$192.40 M(+63.9%)
Mar 2003
-
$117.36 M(+0.0%)
Dec 2002
$117.35 M(-34.3%)
$117.35 M(-33.6%)
Sep 2002
-
$176.66 M(+0.0%)
Jun 2002
-
$176.58 M(-0.6%)
Mar 2002
-
$177.71 M(-0.5%)
Dec 2001
$178.57 M(+6875.5%)
$178.57 M(+1.1%)
Sep 2001
-
$176.55 M(+16.2%)
Jun 2001
-
$151.90 M(+6701.2%)
Mar 2001
-
$2.23 M(-12.8%)
Dec 2000
$2.56 M(-32.6%)
$2.56 M(-24.1%)
Sep 2000
-
$3.37 M(-75.8%)
Jun 2000
-
$13.92 M(+0.7%)
Mar 2000
-
$13.83 M(+263.9%)
Dec 1999
$3.80 M(-25.5%)
$3.80 M(-7.3%)
Sep 1999
-
$4.10 M(-6.8%)
Jun 1999
-
$4.40 M(-8.3%)
Mar 1999
-
$4.80 M(-5.9%)
Dec 1998
$5.10 M(+34.2%)
$5.10 M(+6.3%)
Sep 1998
-
$4.80 M(+65.5%)
Jun 1998
-
$2.90 M(-14.7%)
Mar 1998
-
$3.40 M(-10.5%)
Dec 1997
$3.80 M(+18.8%)
$3.80 M(+58.3%)
Sep 1997
-
$2.40 M(-11.1%)
Jun 1997
-
$2.70 M(-6.9%)
Mar 1997
-
$2.90 M
Dec 1996
$3.20 M
-

FAQ

  • What is CTI BioPharma annual total debt?
  • What is the all time high annual total debt for CTI BioPharma?
  • What is CTI BioPharma annual total debt year-on-year change?
  • What is CTI BioPharma quarterly total debt?
  • What is the all time high quarterly total debt for CTI BioPharma?
  • What is CTI BioPharma quarterly total debt year-on-year change?

What is CTI BioPharma annual total debt?

The current annual total debt of CTIC is $49.96 M

What is the all time high annual total debt for CTI BioPharma?

CTI BioPharma all-time high annual total debt is $233.65 M

What is CTI BioPharma annual total debt year-on-year change?

Over the past year, CTIC annual total debt has changed by -$598.00 K (-1.18%)

What is CTI BioPharma quarterly total debt?

The current quarterly total debt of CTIC is $48.90 M

What is the all time high quarterly total debt for CTI BioPharma?

CTI BioPharma all-time high quarterly total debt is $233.65 M

What is CTI BioPharma quarterly total debt year-on-year change?

Over the past year, CTIC quarterly total debt has changed by +$552.00 K (+1.14%)